Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.39 |
| ▸ | NPY1R | P25929 | 7/20 | 0.39 |
| ▸ | NPY2R | P49146 | 5/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.36 |
| ▸ | NMT2 | O60551 | 1/20 | 0.36 |
| ▸ | NMT1 | P30419 | 1/20 | 0.36 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30111320 | 0.94 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL9614927 | 0.94 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL15011349 | 0.94 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL27732271 | 0.94 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30484000 | 0.91 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31206444 | 0.90 | ENPEP (0.47) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL31410877 | 0.90 | ENPEP (0.40) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL31265334 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31590650 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30912042 | 0.89 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110003336-B | PD-1 single domain antibody, nucleotide sequence and kit | 深圳普瑞金生物药业股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-109970858-B | CD22 single domain antibody, nucleotide sequence and kit | 深圳普瑞金生物药业股份有限公司 | 2023-05-09 | — | — | CN | disclosed |
| EP-4126017-A1 | TNF-ALPHA SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN BE TARGETED TO THERAPY | Baylor College of Medicine (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20200129582-A1 | NOVEL PEPTIDES AND PEPTIDOMIMETICS | INFLAMMX THERAPEUTICS, INC. | 2020-04-30 | — | — | US | disclosed |
| EP-3452072-A2 | NOVEL PEPTIDES AND PEPTIDOMIMETICS | University of Auckland (NZ) | 2019-03-13 | — | — | EP | disclosed |
| CN-109414475-A | New type of peptides and peptide mimics | 奥克兰大学 | 2019-03-01 | — | — | CN | disclosed |
| US-20180008664-A1 | NOVEL PEPTIDES AND PEPTIDOMIMETICS | INFLAMMX THERAPEUTICS, INC. | 2018-01-11 | — | — | US | disclosed |
| WO-2017192620-A2 | NOVEL PEPTIDES AND PEPTIDOMIMETICS | UNIVERSITY OF AUCKLAND (NZ) | 2017-11-09 | — | — | WO | disclosed |